Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Lat...
Q3 2026
Feb 10, 2026
Q2 2026
Nov 4, 2025
Q1 2026
Aug 7, 2025
FY 2025
Jun 17, 2025
Q4 2025